US Patent 12012597 Cancer treatment using siRNA to modulate expression of PRDM2/RIZ protein

Is a

Patent

Patent attributes

Patent Applicant

ARIZ PRECISION MEDICINE

Current Assignee

ARIZ PRECISION MEDICINE

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120125970

Patent Inventor Names

Brad J. Niles0

Jonathan Flynn0

Lonnie L. Bookbinder0

Narendra K. Vaish0

Nicole Nunez0

Date of Patent

June 18, 2024

Patent Application Number

179457390

Date Filed

September 15, 2022

Patent Citations

‌

US Patent 8680045 Compositions of a peptide targeting system for treating cancer

‌

US Patent 9273316 Reagents and methods for treating cancer

‌

US Patent 9358308 Compositions of a peptide targeting system for treating cancer

‌

US Patent 10226424 Therapeutic calcium phosphate nanoparticle incorporating siRNA useful in treating disease

‌

US Patent 10111898 Anti-tumor compositions and methods

‌

US Patent 6989245 Screening, diagnostic and therapeutic methods relating to RIZ

‌

US Patent 7691997 Functional and hyperfunctional siRNA

‌

US Patent 7820809 Functional and hyperfunctional siRNA directed against Bcl-2

...

Patent Primary Examiner

CPC Code

Patent abstract

Inhibitory RNA molecules that specifically inhibit mammalian RIZ2 expression, with therapeutic effect in cell proliferative diseases, such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 12012597 Cancer treatment using siRNA to modulate expression of PRDM2/RIZ protein

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 12012597 Cancer treatment using siRNA to modulate expression of PRDM2/RIZ protein